您当前位置：首页 > 国际期刊-Therapeutic Advances in Drug Safety期刊投稿发表详细信息

Therapeutic Advances in Drug Safety Q2

期刊收录：
SCIE
Scopus
DOAJ

基本信息

期刊ISSN：
2042-0986
期刊简拼：
THER ADV DRUG SAF
年发文章数：
26
E-ISSN：
2042-0994
Gold OA文章占比
94.38%
研究文章占比：
76.92%
是否OA：
Yes
Jcr分区：
Q2
中科院分区：
3区

出版信息

出版商：
SAGE
涉及研究方向：
Medicine-Pharmacology (medical)
出版国家：
ENGLAND
出版语言：
English
出版周期：
出版年份：

2023-2024最新影响因子:3.4
自引率:5.90%
五年影响因子:4
JCI期刊引文指标:0.72
h-index:暂无h-index数据
CiteScore:6.70

期刊关键词

2区 SCIE Scopus DOAJ 医学 3区 PHARMACOLOGY & PHARMACY 药学

期刊简介

Therapeutic Advances in Drug Safety delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients.
The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in drug safety, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest on research across all areas of drug safety, including therapeutic drug monitoring, pharmacoepidemiology, adverse drug reactions, drug interactions, pharmacokinetics, pharmacovigilance, medication/prescribing errors, risk management, ethics and regulation.

《Therapeutic Advances in Drug Safety》期刊已被查看：次
期刊简写：THER ADV DRUG SAF

此期刊被最新的JCR期刊SCIE收录